{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:02:56Z","timestamp":1783483376634,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dry eye disease can compromise the patient\u2019s quality of life. Few studies assessed the ocular surface (OS) in Ankylosing Spondylitis (AS) patients. This study aimed to evaluate the clinical and cytological findings of the OS in patients with AS, classify dry eye disease (DED) severity grade and conjunctival impression cytology (IC), and the effects of TNF inhibitors (TNFi) in a one-year follow-up. A baseline (BL) evaluation included 36 AS patients and 39 healthy controls. They fulfilled the Ocular Surface Index Disease questionnaire and underwent the Schirmer I test, break-up time, vital staining, and conjunctival IC. A DED severity grade, as well as IC rating, was applied. Fourteen of these patients received TNFi and analysis of ocular and systemic AS disease parameters occurred at BL and three months (3\u2009M), and 12 months (12\u2009M) after treatment. The AS patients presented a higher frequency of DED (p\u2009=\u20090.01), a worse score of severity (p\u2009=\u20090.001), and a higher frequency of altered IC (p\u2009=\u20090.007) when compared to controls. The 14 patients under TNFi presented an improvement in all the clinical disease activity parameters throughout the one-year treatment (p\u2009&lt;\u20090.05) even as a concomitant increase in the Schirmer test (p\u2009=\u20090.04), and a significant amelioration in the altered IC to a normal IC (p\u2009=\u20090.006). DED is a frequent and under-diagnosed ocular disease in AS patients. The long-term parallel improvement of disease activity and OS parameters in AS patients receiving TNFi suggests that the OS can be an additional target of systemic inflammation in AS.<\/jats:p>","DOI":"10.1038\/s41598-019-57266-1","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T11:03:00Z","timestamp":1579086180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up"],"prefix":"10.1038","volume":"10","author":[{"given":"Fany Solange","family":"Usuba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Gon\u00e7alves Schahin","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Emi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila","family":"Novaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Cesar Bertacini","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Miyuki","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozelio Freire","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Bonf\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton Ruiz","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"key":"57266_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun, J. & Sieper, J. Ankylosing spondylitis [Review]. Lancet. 369, 1379\u201390 (2007).","journal-title":"Lancet."},{"key":"57266_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00002281-200207000-00001","volume":"14","author":"TM Martin","year":"2002","unstructured":"Martin, T. M., Smith, J. R. & Rosenbaum, J. T. Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathies [Review]. Curr Opin Rheumatol. 14, 337\u201341 (2002).","journal-title":"Curr Opin Rheumatol."},{"key":"57266_CR3","first-page":"2226","volume":"31","author":"R Linder","year":"2004","unstructured":"Linder, R., Hoffmann, A. & Brunner, R. Prevalence of the spondyloarthritides in patients with uveitis. J Rheumatol. 31, 2226\u20139 (2004).","journal-title":"J Rheumatol."},{"key":"57266_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ophtha.2003.07.011","volume":"111","author":"D Monnet","year":"2004","unstructured":"Monnet, D., Breban, M., Hudry, C., Dougados, M. & Br\u00e9zin, A. P. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology. 111, 802\u20139 (2004).","journal-title":"Ophthalmology."},{"key":"57266_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00296-005-0598-6","volume":"25","author":"M Tosun","year":"2005","unstructured":"Tosun, M. et al. Coexisting ankylosing spondylitis and Sjogren\u2019s syndrome: a case report. Rheumatol Int. 25, 478\u201380 (2005).","journal-title":"Rheumatol Int."},{"key":"57266_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10067-006-0255-9","volume":"26","author":"S Kobak.","year":"2007","unstructured":"Kobak., S., Kobak, A. C., Kabasakal, Y. & Doganavsargil, E. Sj\u00f6gren\u2019s syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 26, 173\u20135 (2007).","journal-title":"Clin Rheumatol."},{"key":"57266_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/1753425913498912","volume":"20","author":"L Marsovsky","year":"2014","unstructured":"Marsovsky, L. et al. Corneal Langerhans cell and dry eye examinations in ankylosing spondylitis. Innate Immun. 20, 471\u20137 (2014).","journal-title":"Innate Immun."},{"key":"57266_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","volume":"137","author":"SC Pflugfelder","year":"2004","unstructured":"Pflugfelder, S. C. Antiinflammatory therapy for dry eye [Review]. Am J Ophthalmol. 137, 337\u201342 (2004).","journal-title":"Am J Ophthalmol."},{"key":"57266_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.exer.2005.10.018","volume":"82","author":"D Zoukhri","year":"2006","unstructured":"Zoukhri, D. Effect of inflammation on lacrimal gland function. Exp Eye Res. 82, 885\u201398 (2006).","journal-title":"Exp Eye Res."},{"key":"57266_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig, J. P. et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 15, 276\u2013283 (2017).","journal-title":"Ocul Surf."},{"key":"57266_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","volume":"130","author":"W Stevenson","year":"2012","unstructured":"Stevenson, W., Chauhan, S. K. & Dana, R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 130, 90\u2013100 (2012).","journal-title":"Arch Ophthalmol."},{"key":"57266_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/ACI.0000000000000098","volume":"14","author":"DA Dartt","year":"2014","unstructured":"Dartt, D. A. & Masli, S. Conjunctival epithelial and goblet cell function in chronic inflammation and ocular allergic inflammation. Curr Opin Allergy Clin Immunol. 14, 464\u201370 (2014).","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"57266_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00003226-198801000-00012","volume":"7","author":"JD Nelson","year":"1988","unstructured":"Nelson, J. D. Impression cytology. Cornea. 7, 71\u201381 (1988).","journal-title":"Cornea."},{"key":"57266_CR14","doi-asserted-by":"publisher","first-page":"636812","DOI":"10.1155\/2013\/636812","volume":"2013","author":"L Contreras-Ruiz","year":"2013","unstructured":"Contreras-Ruiz, L., Gosh-Mitra, A., Shatos, M. A., Dartt, D. A. & Masli, S. Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediators Inflamm. 2013, 636812 (2013).","journal-title":"Mediators Inflamm."},{"key":"57266_CR15","doi-asserted-by":"publisher","first-page":"203819","DOI":"10.1155\/2012\/203819","volume":"2012","author":"CL Kraus","year":"2012","unstructured":"Kraus, C. L. & Culican, S. M. Use of biologic agents in ocular manifestations of rheumatic disease. Int J Rheumatol. 2012, 203819 (2012).","journal-title":"Int J Rheumatol."},{"key":"57266_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","volume":"121","author":"G Levy-Clarke","year":"2014","unstructured":"Levy-Clarke, G. et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 121, 785\u201396 (2014).","journal-title":"Ophthalmology."},{"key":"57266_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.ICL.0000092064.05514.04","volume":"30","author":"M Hernandez-Illas","year":"2004","unstructured":"Hernandez-Illas, M. et al. Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration. Eye Contact Lens. 30, 2\u20135 (2004).","journal-title":"Eye Contact Lens."},{"issue":"2","key":"57266_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1740-2557-2-6","volume":"28","author":"MD Trousdale","year":"2005","unstructured":"Trousdale, M. D. et al. Expression of TNF inhibitor gene in the lacrimal gland promotes recovery of tear production and tear stability and reduced immunopathology in rabbits with induced autoimmune dacryoadenitis. J Autoimmune Dis. 28(2), 6 (2005).","journal-title":"J Autoimmune Dis."},{"issue":"Suppl 1","key":"57266_CR19","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/ICO.0b013e31826a80ea","volume":"11","author":"Z Li","year":"2012","unstructured":"Li, Z., Choi, W., Oh, H. J. & Yoon, K. C. Effectiveness of topical infliximab in a mouse model of experimental dry eye. Cornea. 11(Suppl 1), S25\u2013S31 (2012).","journal-title":"Cornea."},{"key":"57266_CR20","first-page":"1392","volume":"12","author":"H Liang","year":"2006","unstructured":"Liang, H. et al. In vivo confocal microscopy and ex vivo flow cytometry: new tools for assessing ocular inflammation applied to rabbit lipopolysaccharide-induced conjunctivitis. Mol Vis. 12, 1392\u2013402 (2006).","journal-title":"Mol Vis."},{"key":"57266_CR21","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/art.20299","volume":"50","author":"V Sankar","year":"2004","unstructured":"Sankar, V. et al. Etanercept in Sj\u00f6gren\u2019s syndrome: a twelve-week randomized, double-blinded, placebo-controlled pilot clinical trial. Arthritis Rheum. 50, 2240\u20135 (2004).","journal-title":"Arthritis Rheum."},{"key":"57266_CR22","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/art.20146","volume":"50","author":"X Mariette","year":"2004","unstructured":"Mariette, X. et al. Inefficacy of infliximab in primary Sj\u00f6gren\u2019s syndrome: results of the randomized controlled Trial of Remicade in Primary Sj\u00f6gren\u2019s Syndrome (TRIPSS). Arthritis Rheum. 50, 1270\u20136 (2004).","journal-title":"Arthritis Rheum."},{"key":"57266_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Van Der Linden","year":"1984","unstructured":"Van Der Linden, S., Valkenburg, H. A. & Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27, 361\u20138 (1984).","journal-title":"Arthritis Rheum."},{"key":"57266_CR24","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1093\/rheumatology\/kes026","volume":"51","author":"X Baraliakos","year":"2012","unstructured":"Baraliakos, X., Van Den Berg, R., Braun, J. & Van Der Heijde, D. Update of the literature review on treatment with biologics as a basis for the first update of the ASAS\/Eular management recommendations of ankylosing spondylitis. Rheumatology. 51, 1378\u201387 (2012).","journal-title":"Rheumatology."},{"key":"57266_CR25","first-page":"43","volume":"10","author":"KA Beckman","year":"2016","unstructured":"Beckman, K. A., Luchs, J. & Milner, M. S. Making the diagnosis of Sj\u00f6gren\u2019s syndrome in patients with dry eye. Clin Ophthalmol. 10, 43\u201353 (2016).","journal-title":"Clin Ophthalmol."},{"key":"57266_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","volume":"149","author":"JP Whitcher","year":"2010","unstructured":"Whitcher, J. P. et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren\u2019s Syndrome International Registry. Am J Ophthalmol. 149, 405\u2013415 (2010).","journal-title":"Am J Ophthalmol."},{"key":"57266_CR27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jclinepi.2014.07.009","volume":"68","author":"RM Santo","year":"2015","unstructured":"Santo, R. M., Ribeiro-Ferreira, F., Alves, M. R., Epstein, J. & Novaes, P. Enhancing the cross-cultural adaptation and validation process: linguistic and psychometric testing of the Brazilian-Portuguese version of a self-report measure for dry eye. J Clin Epidemiol. 68, 370\u20138 (2015).","journal-title":"J Clin Epidemiol."},{"key":"57266_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman, R. M., Christianson, M. D., Jacobsen, G., Hirsch, J. D. & Reis, B. L. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 118, 615\u201321 (2000).","journal-title":"Arch Ophthalmol."},{"key":"57266_CR29","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 5, 75\u201392 (2007).","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"57266_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.exer.2015.04.007","volume":"136","author":"MJ Doughty","year":"2015","unstructured":"Doughty, M. J. A systematic assessment of goblet cell sampling of the bulbar conjunctiva by impression cytology. Exp Eye Res. 136, 16\u201328 (2015).","journal-title":"Exp Eye Res."},{"key":"57266_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jtos.2013.02.002","volume":"11","author":"M Alves","year":"2013","unstructured":"Alves, M. et al. Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul Surf. 11, 181\u201392 (2013).","journal-title":"Ocul Surf."},{"key":"57266_CR32","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/bjophthalmol-2013-304619","volume":"98","author":"C Baudoin","year":"2014","unstructured":"Baudoin, C. et al. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol. 98, 1168\u201376 (2014).","journal-title":"Br J Ophthalmol."},{"key":"57266_CR33","doi-asserted-by":"crossref","first-page":"285851","DOI":"10.1155\/2012\/285851","volume":"2012","author":"FT Fraunfelder","year":"2012","unstructured":"Fraunfelder, F. T., Sciubba, J. J. & Mathers, W. D. The role of medications in causing dry eye. J Ophthalmol. 2012, 285851 (2012).","journal-title":"J Ophthalmol."},{"key":"57266_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/aos.12012","volume":"92","author":"BD Sullivan","year":"2014","unstructured":"Sullivan, B. D. et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 92, 161\u20136 (2014).","journal-title":"Acta Ophthalmol."},{"key":"57266_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","volume":"15","author":"DA Sullivan","year":"2017","unstructured":"Sullivan, D. A. et al. TFOS DEWS II Sex Gender, and Hormones Report. Ocul Surf. 15, 284\u2013333 (2017).","journal-title":"Ocul Surf."},{"key":"57266_CR36","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1167\/iovs.11-9228","volume":"53","author":"E Viso","year":"2012","unstructured":"Viso, E., Rodriguez-Ares, M. T., Abelenda, D., Oubi\u00f1a, B. & Gude, F. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci. 53, 2601\u20136 (2012).","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"2S","key":"57266_CR37","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","volume":"12","author":"AJ Bron","year":"2014","unstructured":"Bron, A. J. et al. Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf. 12(2S), S1\u2013S31 (2014).","journal-title":"Ocul Surf."},{"key":"57266_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/08820538.2015.1068340","volume":"32","author":"A Gunes","year":"2017","unstructured":"Gunes, A., Erkol Inal, E., Tok, L. & Tok, O. Assessment of corneal parameters with Scheimpflug imaging in patients with ankylosing spondylitis. Semin Ophthalmol. 32, 276\u201380 (2017).","journal-title":"Semin Ophthalmol."},{"key":"57266_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10792-013-9827-2","volume":"34","author":"H Ortak","year":"2014","unstructured":"Ortak, H. et al. Decreased central corneal thickness in ankylosing spondylitis. Int Ophthalmol. 34, 263\u20138 (2014).","journal-title":"Int Ophthalmol."},{"key":"57266_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","volume":"27","author":"SC Pflugfelder","year":"2008","unstructured":"Pflugfelder, S. C., De Paiva, C. S., Villareal, A. L. & Stern, M. E. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-\u03b22 production. Cornea. 27, 64\u201369 (2008).","journal-title":"Cornea."},{"key":"57266_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajo.2015.04.008","volume":"160","author":"QL Moore","year":"2015","unstructured":"Moore, Q. L., De Paiva, C. S. & Pflugfelder, S. C. Effects of dry eye therapies on environmentally induced ocular surface disease. Am J Ophthalmol. 160, 135\u201342 (2015).","journal-title":"Am J Ophthalmol."},{"key":"57266_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0002-9394(03)00326-X","volume":"136","author":"AM Avunduk","year":"2003","unstructured":"Avunduk, A. M., Avunduk, M. C., Varnell, E. D. & Kaufman, H. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol. 136, 593\u2013602 (2003).","journal-title":"Am J Ophthalmol."},{"key":"57266_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/09273940701299354","volume":"15","author":"M Cordero-Coma","year":"2007","unstructured":"Cordero-Coma, M., Anzaa, rF., Sobrin, L. & Foster, C. S. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immunol Inflamm. 15, 99\u2013104 (2007).","journal-title":"Ocul Immunol Inflamm."},{"key":"57266_CR44","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones, L. et al. TFOS DEWS II Management and Therapy report. Ocul Surf. 15, 1575\u2013628 (2017).","journal-title":"Ocul Surf."},{"key":"57266_CR45","doi-asserted-by":"publisher","first-page":"7557","DOI":"10.1167\/iovs.12-11515","volume":"54","author":"YW Ji","year":"2013","unstructured":"Ji, Y. W. et al. Neutralization of the ocular surface TNF-\u03b1 reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye. Invest Ophthalmol Vis Sci. 54, 7557\u201366 (2013).","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"57266_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0161-6420(97)30330-3","volume":"104","author":"SC Pflugfelder","year":"1997","unstructured":"Pflugfelder, S. C. et al. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology. 104, 223\u201335 (1997).","journal-title":"Ophthalmology."},{"key":"57266_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1542-0124(12)70043-5","volume":"4","author":"P Buchholz","year":"2006","unstructured":"Buchholz, P. et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf. 4, 155\u201361 (2006).","journal-title":"Ocul Surf."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57266-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57266-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57266-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:32:53Z","timestamp":1670304773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-57266-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["57266"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-57266-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"assertion":[{"value":"29 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"334"}}